The Endocrine Disruptor Page HomeSitemap
@

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
@

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


@
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.2.3.2

@

contents  Detailed contents  << prev  next >>

@

[Preparation of sample solutions]5
Place 1 ml serum in a 10 ml stoppered glass test tube. Add 5 ml acetonitrile, 0.5 g sodium chloride, 1 ml n-hexane and 25ƒÊl internal standard solution (4ƒÊg/ml), and shake for 3 min. After centrifuging the solution for 5 min at 3000 rpm, separate the acetonitrile layer and distil under reduced pressure. Dissolve the residue in 2 ml purified water, and extract two times with 5 ml and 3 ml n-hexane, respectively. Charge the Florisil-PSA column with the n-hexane layer, wash with 3 ml n-hexane, and elute PAE with 10 ml 5% acetone-n-hexane. Concentrate the eluent under reduced pressure, and add n-hexane to 1 ml.

[Procedure for quantitative analysis]6
(i) Typical GC/MS conditions
Column: Fused silica capillary column, 0.25 mm i.d., 30 m long, film thickness 0.25ƒÊm; phenylmethylsilicone as the liquid phase7
Column temperature: 80Ž, 3 min -> 10Ž/min -> 300Ž, 5 min
Carrier gas: Helium, total flow rate 50 ml/min, column flow rate 1.5 ml/min
Injection port temperature: 240Ž
Injection mode: Splitless
Interface temperature: 300Ž
Detection method: SIM
Monitor ions: See below.

contents  Detailed contents  << prev  next >>

@

@

About links, copyright, etc.b Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.